ALLON THERAPEUTICS
Allon Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs to treat neurodegenerative diseases. Its lead product, Davunetide intranasal, an intranasal drug product, which is in Phase IIa clinical trial for the treatment for Alzheimer's disease, schizophrenia cognitive impairment, and frontotemporal dementia. The company is also evaluating davunetide intravenous in a Phase IIa clinical trial for patients who had undergone coronary artery bypass surger... y; and AL-309, a pre-clinical compound that has demonstrated efficacy in animal models related to neuropathy, Alzheimer's disease, and fetal alcohol syndrome. It has collaborations with the National Institute of Aging, the Alzheimer's Disease Cooperative Study, the Institute for the Study of Aging, and the Tel Aviv University. The company was formerly known as Neuro Discovery Inc. and changed its name in September 2004 to Allon Therapeutics Inc. as a result of acquisition of Allon Therapeutics, Inc. The company is headquartered in Vancouver, Canada.
ALLON THERAPEUTICS
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2001-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.allontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+16047361616
Email Addresses:
[email protected]
Total Funding:
11.63 M USD
Technology used in webpage:
Register.com DNS
Similar Organizations
4P-Pharma
4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
ActiveRADAR
ActiveRADAR is a healthcare analytics company offering data-driven prescription solutions and affordable therapeutic alternative services.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Current Employees Featured
Stock Details
Investors List
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Equity - Allon Therapeutics
Official Site Inspections
http://www.allontherapeutics.com
- Host name: 154.16.249.137
- IP address: 154.16.249.137
- Location: South Africa
- Latitude: -29
- Longitude: 24
- Timezone: Africa/Johannesburg
More informations about "Allon Therapeutics"
Allon Therapeutics - Crunchbase Company Profile & Funding
Allon Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs to treat neurodegenerative diseases. Its lead product, Davunetide intranasal, an โฆSee details»
Allon Therapeutics Inc (NPCUF) Profile - The Globe and Mail
See the company profile for Allon Therapeutics Inc (NPCUF) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Allon Therapeutics Inc. (NPCUF) Company Profile & Facts - Yahoo โฆ
See the company profile for Allon Therapeutics Inc. (NPCUF) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Allon Therapeutics - 2025 Company Profile - Tracxn
Feb 27, 2025 How much funding has Allon Therapeutics raised till date? Allon Therapeutics. has raised a total funding of $500K over 3 rounds.. Its first funding round was on Nov 10, 2004.See details»
Allon Therapeutics Inc. - Vancouver, Canada - bionity.com
Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. In Q1 2008, Allonโs drug AL-108 demonstrated human efficacy โฆSee details»
Allon Therapeutics Inc. - Dun & Bradstreet
Company Description: Allon Therapeutics wants to make Alzheimer's a distant memory and halt other progressive brain diseases. The company's primary focus is on developing treatments โฆSee details»
Allon Therapeutics Inc. (NPCUF) - Yahoo Finance Canada
See the company profile for Allon Therapeutics Inc. (NPCUF) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Allon Therapeutics Inc. - VentureRadar
Morpheus Biolabs USA n/a Morpheus BioLabs is a Contract Research Organization (CRO) that is specialized in providing biomedical research and consulting services to pharmaceuticals, โฆSee details»
Allon Therapeutics, Inc.:Company Profile & Technical Research ...
Allon Therapeutics, Inc. is a company that provides Clinical trial, Alzheimer's disease, Pharmacy and Therapeutics and more. Allon Therapeutics, Inc. is headquartered in Canada British โฆSee details»
Company Allon Therapeutics Inc. Other OTC - MarketScreener.com
Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical โฆSee details»
Allon Therapeutics Company Profile | Management and ... - Datanyze
Find contact information for Allon Therapeutics. Learn about their Business Services market share, competitors, and Allon Therapeutics's email format.See details»
Allon Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 17, 2012: Post-IPO Equity โฆSee details»
Allon Therapeutics - Products, Competitors, Financials, Employees ...
Allon is developing technology that has demonstrated potent neuroprotective capabilities in pre-clinical studies in a wide range of chronic and acute neurodegenerative diseases and โฆSee details»
Allon Therapeutics Management Team | Org Chart - RocketReach
Allon Therapeutics employs 2 employees. The Allon Therapeutics management team includes Patrick Ruane (Chief Operating Officer), Randall Murphy (CSO and Chief Operating Officer), โฆSee details»
Allon Therapeutics, Inc. | Alzheimer's Drug Discovery Foundation
Nov 22, 2002 View all funding to this organization (1) View all funding to this investigator (3) GET IN TOUCH. [email protected]; 212.901.8000; Alzheimer's Drug Discovery โฆSee details»
Allon Therapeutics seeks liquidation after dementia drug flops
May 31, 2013 Allon Therapeutics has run short on options after the failure of its top candidate in a Phase II/III study last year for a form of dementia called progressive supranuclear palsy.See details»
Allon Therapeutics Inc. Stock Toronto S.E. - MarketScreener.com
Dec 31, 2012 Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical โฆSee details»
Allon Therapeutics, Inc. (Allon Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
Background/Aims: AL-108-211 was a placebo-controlled, ascending-dose study that explored the safety, tolerability and efficacy of 12 weeks of treatment with AL-108 in subjects with amnestic โฆSee details»
Alteron Therapeutics - VentureRadar
"Alteron Therapeutics is a biopharmaceutical company dedicated to developing TDP-43 inhibitors for the treatment of neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), โฆSee details»